# Companies 101–107 — Native Current-Standard Verification

**Status:** VERIFIED PLANNING-MAP CONFORMANCE  
**Scope:** source-roadmap verification only; no implementation, production, customer, legal, financial or commercial completion claim.

## Why no supplemental roadmaps were created

Companies 101–107 were authored natively in the newer `v2.0.0` roadmap format. Each source declares exhaustive 28-pass / A–BZ mapping and includes the final BU–BZ current-standard fields: reuse candidates, proven dependency rules, company-specific capability, external dependencies to internalize, blast-radius analysis, version/compatibility and final saturation. Creating duplicate generic supplements would reduce clarity rather than add missing architecture.

## Verification table

| Company | Source | Native version | Result |
|---|---|---:|---|
| 101 — Healthcare Administrative Automation OS | `../101_HEALTHCARE_ADMINISTRATIVE_AUTOMATION_OS.md` | `COMPANY-101-v2.0.0` | 28-pass + A–BZ native conformance verified |
| 102 — E-Discovery & Litigation Evidence Intelligence Platform | `../102_E_DISCOVERY_AND_LITIGATION_EVIDENCE_INTELLIGENCE_PLATFORM.md` | `COMPANY-102-v2.0.0` | 28-pass + A–BZ native conformance verified |
| 103 — KYC / KYB / AML Compliance Infrastructure | `../103_KYC_KYB_AML_COMPLIANCE_INFRASTRUCTURE.md` | `COMPANY-103-v2.0.0` | 28-pass + A–BZ native conformance verified |
| 104 — Privacy-Preserving Data Collaboration Platform | `../104_PRIVACY_PRESERVING_DATA_COLLABORATION_PLATFORM.md` | `COMPANY-104-v2.0.0` | 28-pass + A–BZ native conformance verified |
| 105 — Global Trade & Customs Compliance Autopilot | `../105_GLOBAL_TRADE_AND_CUSTOMS_COMPLIANCE_AUTOPILOT.md` | `COMPANY-105-v2.0.0` | 28-pass + A–BZ native conformance verified |
| 106 — Insurance Claims Automation & Claims Intelligence Platform | `../106_INSURANCE_CLAIMS_AUTOMATION_AND_CLAIMS_INTELLIGENCE_PLATFORM.md` | `COMPANY-106-v2.0.0` | 28-pass + A–BZ native conformance verified |
| 107 — Rights, Royalties & Licensing Operations Platform | `../107_RIGHTS_ROYALTIES_AND_LICENSING_OPERATIONS_PLATFORM.md` | `COMPANY-107-v2.0.0` | 28-pass + A–BZ native conformance verified |

## Boundary verification

- **101:** non-clinical healthcare administration; no autonomous clinical decisions; PHI/privacy and payer/provider standards remain domain-specific.
- **102:** matter/client isolation, privilege/hold/production integrity; counsel retains legal/privilege/production authority.
- **103:** identity/KYB/UBO/watchlist/risk/case infrastructure; high-risk compliance decisions and regulatory filings remain governed/human.
- **104:** privacy-preserving computation/clean rooms; cryptographic confidentiality does not create lawful permission; raw participant data does not become shared Brain memory.
- **105:** customs/trade classification, origin, sanctions/export controls and shipment gates; filings, licenses, restricted-party legal decisions and payments remain protected.
- **106:** claims evidence/triage/estimate/reconciliation intelligence; coverage, liability, fraud accusation, reserve, settlement and payment authority remain protected.
- **107:** rights/ownership/chain-of-title/contracts/usage/royalty math/reconciliation; disputed ownership, legal interpretation, license grants, infringement assertions and material royalty payments remain protected.

## Cross-portfolio verification

Each native roadmap preserves:

1. Command Center as orchestrator rather than specialist domain Brain.
2. Company/customer data isolation.
3. Deterministic truth/action gates for material decisions.
4. Source/provenance/version evidence.
5. Human/legal review where domain ambiguity or regulated authority requires it.
6. Reuse only through proof/compatibility, with forkability for company-specific needs.
7. Explicit blast radius and rollback/recovery expectations.
8. No automatic activation of companies, providers, spend, public launch or production execution.

## Result

Companies 101–107 require no additional company-specific conformance supplement at this checkpoint. Their source roadmaps are the canonical current-standard maps. Portfolio-wide shared-capability implications are reconciled in `../../123_107_COMPANY_REVERSE_MAP_AND_COMMAND_CENTER_RETROFIT_PLAN.md`.